BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beatty GL, Werba G, Lyssiotis CA, Simeone DM. The biological underpinnings of therapeutic resistance in pancreatic cancer. Genes Dev 2021;35:940-62. [PMID: 34117095 DOI: 10.1101/gad.348523.121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mammarella E, Zampieri C, Panatta E, Melino G, Amelio I. NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network. Biol Direct 2021;16:11. [PMID: 34348766 DOI: 10.1186/s13062-021-00296-5] [Reference Citation Analysis]
2 Bots ST, Kemp V, Cramer SJ, van den Wollenberg DJ, Hornsveld M, Lamfers M, van der Pluijm G, Hoeben RC. Non-human primate adenoviruses of the Human Adenovirus B species are potent and broadly-acting oncolytic vector candidates. Hum Gene Ther 2021. [PMID: 34861769 DOI: 10.1089/hum.2021.216] [Reference Citation Analysis]
3 Wattenberg MM, Reiss KA. Determinants of Homologous Recombination Deficiency in Pancreatic Cancer. Cancers (Basel) 2021;13:4716. [PMID: 34572943 DOI: 10.3390/cancers13184716] [Reference Citation Analysis]